February 22, 2026
Headlines

Why Is Pediatric-Cancer Focused OS Therapies Stock Trading Higher On Wednesday?

Sumain Faisal01 mins

OS Therapies shares Phase 2b trial results showing OST-HER2 improves survival rates in rare metastatic osteosarcoma, surpassing historical controls.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News